Adage Capital Partners Gp, L.L.C. Nex Immune, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $1 Million - $1.64 Million	97,000 Added 13.77%	801,371 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$14.98 - $23.89 $3.06 Million - $4.88 Million	204,371 Added 40.87%	704,371 $11.5 Million
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $8.98 Million - $13 Million	500,000 New	500,000 $9.54 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.